Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2026-01-02 @ 8:47 AM
Study NCT ID:
NCT00948766
Status:
COMPLETED
Last Update Posted:
2013-08-28
First Post:
2009-07-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44
Sponsor:
Novartis
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-07
Start Date Type:
None
Primary Completion Date:
2012-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-06
Completion Date Type:
ACTUAL
First Submit Date:
2009-07-28
First Submit QC Date:
None
Study First Post Date:
2009-07-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-01-08
Results First Submit QC Date:
None
Results First Post Date:
2013-02-11
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-08-19
Last Update Post Date:
2013-08-28
Last Update Post Date Type:
ESTIMATED